.png){kind=logo}
GC Asia
Pfizer underscores insatiable demand theory
In what is becoming a familiar theme, US drug company Pfizer this week issued an acquisition related high grade bond that swiftly dropped to much lower yields after pricing.
It was priced only four weeks after Roche, another pharmaceutical, brought $16.5bn in the biggest US dollar bond offering yet.
This ...Already a subscriber? Login
-
Latest news from Corporate Bonds
-
Crunch time coming for Europe’s corporates
03 Jul 2020 -
JG Summit ends seven year hiatus with $600m bond
03 Jul 2020 -
Critical hedge fund sees better way to do ESG
02 Jul 2020 -
Rhätische Bahn sells second ever Swiss franc deal
02 Jul 2020 -
Takeda gets large dose in holidaying US mart
02 Jul 2020
-
-
Latest news from Corporate Bonds
-
Crunch time coming for Europe’s corporates
03 Jul 2020 -
JG Summit ends seven year hiatus with $600m bond
03 Jul 2020 -
Critical hedge fund sees better way to do ESG
02 Jul 2020 -
Rhätische Bahn sells second ever Swiss franc deal
02 Jul 2020 -
Takeda gets large dose in holidaying US mart
02 Jul 2020
-
 from co for use 575x375.jpg)
